Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000318306-18-000001
Filing Date
2018-04-02
Accepted
2018-04-02 20:14:36
Documents
1
Period of Report
2018-03-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2165
  Complete submission text file 0000318306-18-000001.txt   3859
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALEXION PHARMACEUTICALS 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
Thiel Carsten (Reporting) CIK: 0001633582 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15771 | Film No.: 18731014